Covalon Technologies EBITDA TCAC 5A

Que fait Covalon Technologies ? Covalon Technologies Ltd. develops and markets patent-protected medical products including advanced wound care solutions, infection prevention technologies, and medical device coatings. The company sells products under its own brand name and also creates medical products for other medical companies through development and license contracts. Its solutions target patients requiring gentle healing with reduced infections and pain, while also serving care providers with specialized medical devices, dressings, and perioperative care systems. The company's portfolio includes antimicrobial skin protection, postoperative incision care, and scar prophylaxis solutions designed for comprehensive patient care from pre-operative to postoperative stages. Covalon's revenue streams come from direct sales of its branded products and licensing agreements with other medical companies for product development. The primary customers are healthcare providers and hospitals seeking advanced wound care and infection prevention solutions. The company focuses on medical device coatings, wound care products, and perioperative care systems as key segments within the medical technology market. Its patented technologies enable both direct product sales and collaborative development partnerships with other medical companies. The company's business model relies on two main revenue channels: selling Covalon-branded medical products directly to healthcare providers and generating income through development and license contracts with other medical companies. Its solutions are designed for patients and made for care providers, emphasizing gentle healing with less infections and pain. The company's product portfolio includes antimicrobial protection for pre-operative skin, postoperative incision care, and scar prophylaxis as part of its perioperative care offerings. Covalon Technologies est l'une des entreprises les plus populaires sur Eulerpool.